Notícias e Atividades da Lumos Pharma

Lumos Pharma é uma empresa listada sob o símbolo LUMO (US).

Veja o organograma con seus 22 executivos principais

Biografias mais buscadas da Lumos Pharma

• Rick Hawkins, Chief Executive Officer, President and Chairman
• Joe McCracken, Director
• Chad Johnson, Board Member

Criar um alerta
para seguir os movimentos de executivos da Lumos Pharma.

Lumos Pharma possui 1.833 concorrentes concorrentes Pfizer (Estados Unidos), Eli Lilly (Estados Unidos) e Sanofi (França).

Popular M&A news in Farmacêutica

• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado em 12 de março de 2025).
• Jazz Pharmaceuticals adquiriu Chimerix (publicado em 6 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Paul Meister - Chairman of the Board da Amneal Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica >

Últimos comunicados de imprensa de Lumos Pharma

• Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November | Lumos Pharma
• Press Releases | Lumos Pharma
• Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints | Lumos Pharma
• Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates | Lumos Pharma
• Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting | Lumos Pharma
• Lumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meeting | Lumos Pharma
• Lumos Pharma Announces Participation in Investor Conferences in September | Lumos Pharma
• Independent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscape | Lumos Pharma
• Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022 | Lumos Pharma
• CEO Update: Interview with Lumos Pharma’s Chief Medical Officer, David B. Karpf, M.D. | Lumos Pharma
• View more press releases Close

Redes sociais sobre Lumos Pharma

• Lumos Pharma na Wikipedia, Google News e Yahoo Finance
• Lumos Pharma na LinkedIn, Twitter e YouTube